Preclinical assessment of targeting DCs directly in vivo to prevent human islet transplant rejection as a cure for Type 1 diabetes

Lombardi, G. (Primary Investigator), Huang, G. (Co-Investigator), Jones, P. (Co-Investigator), Lechler, R. (Co-Investigator) & Xiao, F. (Co-Investigator)

1/01/2016 → 31/12/2018

Project: Research

Preclinical assessment of targeting DCs directly in vivo to prevent human islettransplant rejection as a cure for Type 1 diabetes

Lombardi, G. (Primary Investigator), Huang, G. (Co-Investigator), Jones, P. (Co-Investigator), Lechler, R. (Co-Investigator) & Xiao, F. (Co-Investigator)

1/01/2016 → 31/12/2018

Project: Research

Preclinical assessment of targeting DCs directly in vivo to prevent human islet transplant rejection as a cure for Type 1 diabetes

Lombardi, G. (Primary Investigator), Huang, G. (Co-Investigator), Jones, P. (Co-Investigator), Lechler, R. (Co-Investigator) & Xiao, F. (Co-Investigator)

1/01/2016 → 31/12/2018

Project: Research

Pilot study for the evaluation of the safety of a novel immune-isolating device for immunosuppression free islet transplantation

Choudhary, P. (Primary Investigator), Amiel, S. (Co-Investigator), Bornstein, S. (Co-Investigator) & Huang, G. (Co-Investigator)

Diabetes UK

1/02/2015 → 31/08/2018

Project: Research

Optimising Islet survival/performance by cytotopic inhibition of thrombin & protease activated receptors; a strategy for clinical translation.

Dorling, A. (Primary Investigator), Chen, D. (Co-Investigator), Huang, G. (Co-Investigator) & Jones, P. (Co-Investigator)

1/06/2014 → 31/05/2017

Project: Research